Profile data is unavailable for this security.
About the company
Qingdao Vland Biotech Inc is a China-based company principally engaged in the research, development, production, and sales of enzyme preparations, microecological preparations, and animal health products. The Company operates through two main segments. The Biological segment primarily includes enzyme preparations and microecological products. The Animal Health segment mainly covers veterinary chemical drugs, traditional Chinese veterinary medicines, and biological products. The Company provides technological support for biomanufacturing, clean and energy-saving solutions for traditional industries, and green solutions for food safety. The Company’s products and services are applied in agriculture, food, cleaning, health, environmental protection, and biocatalysis industries. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)1.39bn
- Net income in CNY83.57m
- Incorporated2005
- Employees1.57k
- LocationQingdao Vland Biotech IncNo. 596-1Jiushui East Road, Laoshan DistrictQINGDAO 266100ChinaCHN
- Phone+86 53 288978071
- Fax+86 53 288966609
- Websitehttp://www.vlandgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 393.73m | 50.20m | 3.59bn | 731.00 | 71.38 | 4.52 | -- | 9.11 | 0.1307 | 0.1307 | 1.02 | 2.06 | 0.3503 | 1.94 | 1.88 | 538,619.70 | 4.47 | -4.60 | 6.16 | -6.38 | 51.82 | 24.75 | 12.75 | -16.33 | 1.81 | -- | 0.00 | -- | 4.46 | 8.04 | 219.75 | 3.82 | -0.975 | -- |
| Qingdao Vland Biotech INC | 1.39bn | 83.57m | 4.02bn | 1.57k | 48.33 | 2.27 | -- | 2.89 | 0.329 | 0.329 | 5.50 | 7.01 | 0.4585 | 3.89 | 3.65 | -- | 3.76 | 4.84 | 6.11 | 6.94 | 44.19 | 45.52 | 8.20 | 9.54 | 0.877 | -- | 0.2648 | 32.35 | 10.16 | 9.30 | -22.39 | -4.23 | -2.71 | -6.89 |
| Hinova Pharmaceuticals Inc | 23.61m | -144.57m | 4.56bn | 173.00 | -- | 4.15 | -- | 193.34 | -1.46 | -1.46 | 0.2384 | 11.12 | 0.0171 | 2.37 | 5.59 | 136,467.70 | -10.45 | -26.09 | -11.68 | -29.74 | 95.50 | -- | -612.36 | -78,863.60 | 6.90 | -- | 0.0883 | -- | -- | -38.67 | 32.18 | -- | 139.77 | -- |
| Shanghai Aladdin Biochemical Tech Co Ltd | 599.98m | 83.95m | 5.33bn | 652.00 | 64.42 | 4.99 | -- | 8.88 | 0.2485 | 0.2485 | 1.78 | 3.21 | 0.2785 | 0.4218 | 4.55 | 920,216.30 | 5.04 | 7.81 | 6.90 | 8.60 | 62.21 | 60.61 | 18.09 | 24.95 | 1.53 | 9.15 | 0.3541 | 48.33 | 32.44 | 20.55 | 15.07 | 9.17 | 41.61 | -- |
| Hangzhou Alltest Biotech Co Ltd | 881.63m | 294.76m | 5.48bn | 969.00 | 18.55 | 1.40 | -- | 6.21 | 3.72 | 3.72 | 11.12 | 49.21 | 0.2098 | 2.38 | 6.39 | 909,839.10 | 7.02 | 19.18 | 7.57 | 21.66 | 55.00 | 57.79 | 33.47 | 38.82 | 8.34 | -- | 0.0093 | 35.14 | 14.83 | 29.13 | 67.50 | 30.99 | 71.01 | -- |
| Bide Pharmatech Co Ltd | 1.27bn | 153.31m | 5.49bn | 738.00 | 34.35 | 2.74 | -- | 4.32 | 1.76 | 1.76 | 14.49 | 22.03 | 0.5167 | 0.8804 | 5.25 | 1,720,520.00 | 6.24 | 7.02 | 7.52 | 8.29 | 43.30 | 42.16 | 12.07 | 13.13 | 2.78 | -- | 0.1055 | 48.73 | 0.9298 | 34.69 | 7.17 | -- | 80.65 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 1.44m | 0.66% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 250.20k | 0.12% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 221.00k | 0.10% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 55.30k | 0.03% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2025 | 54.10k | 0.03% |
| CCB Principal Asset Management Co., Ltd.as of 29 Feb 2024 | 44.90k | 0.02% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 42.40k | 0.02% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 39.00k | 0.02% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 33.80k | 0.02% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2025 | 17.30k | 0.01% |
